2011
DOI: 10.1038/ng.801
| |Summarize |Cite
|
Sign up to set email alerts

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Abstract: The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3). Both joint and meta-analysis analysis approaches were used. We obtained genome-wide significant results at MS4A4A [rs4938933; Stages 1+2, meta-analysis (PM) = 1.7 × 10−9, joint analysis (PJ) = 1.7 × 10−9; Stages 1–3, PM = 8.2 × 10−12], CD2AP (rs9349407; Stages 1–3, PM… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
1,482
413
200
128

Citation Types

47
1,690
12
8

Year Published

Range
2008
2008
2027
2027

Publication Types

Select...
1,630
188
168
102

Relationship

203
1,885

Authors

Journals

Cited by 2,083 publications

(1,757 citation statements)

References 40 publications

47
1,690
12
8
Order By: Relevance
How the paper below cites the one you are viewing
“…Two associations near APOE , rs2075650 ( P = 2.05 × 10 −5 ) and rs4420638 ( P = 2.58 × 10 −6 ), surpassed this predefined P value threshold (eTable 1 in the Supplement). While the other tested GWAS variants were not significantly associated with AD, the overall direction of the association was highly consistent with previously reported results, 3–5 and 23 of 32 SNPs for which the risk allele was unambiguous showed the same direction of effect as previously reported ( P = .010, binomial test).…”
Section: Results
supporting
confidence: 91%